We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

117 hedge funds and large institutions have $346M invested in ChemoCentryx, Inc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 56 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 31

12% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 17

0% more funds holding

Funds holding: 117117 (0)

26% less capital invested

Capital invested by funds: $469M → $346M (-$123M)

57% less call options, than puts

Call options by funds: $2.46M | Put options by funds: $5.71M

Holders
117
Holders Change
Holders Change %
0%
% of All Funds
2.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
56
Reduced
31
Closed
17
Calls
$2.46M
Puts
$5.71M
Net Calls
-$3.25M
Net Calls Change
-$3.63M
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Trading
126
Walleye Trading
New York
-$206K -14,800 Closed
SCA
127
Secor Capital Advisors
New York
-$178K -12,798 Closed
WG
128
Winton Group
United Kingdom
-$176K -12,677 Closed
ECM
129
Element Capital Management
New York
-$165K -11,906 Closed
ECM
130
ExodusPoint Capital Management
New York
-$144K -10,361 Closed
KPW
131
Kore Private Wealth
New York
-$28K -2,000 Closed
LC
132
Lindbrook Capital
California
-$10K -750 Closed
QI
133
QS Investors
New York
-$9K -643 Closed
DWA
134
Dorsey Wright & Associates
California
-$8K -585 Closed

CCXI Hedge Fund Activity: Q2 2019 in Review

117 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2019, worth a combined $346M — down 26% from $469M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CCXI positions and 17 closed out — a net gain of 2 holders — while 56 added to existing stakes and 31 trimmed.

The largest buyer was State Street, adding an estimated $15.5M. The largest seller was Sio Capital Management, exiting entirely with an estimated $6.14M sold.

  • 117 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $346M of ChemoCentryx, Inc. stock for Q2 2019, down 26% quarter-over-quarter.
  • 19 funds opened new ChemoCentryx, Inc. positions in Q2 2019 and 17 closed out, a net change of +2 holders.
  • The largest ChemoCentryx, Inc. buyer in Q2 2019 was State Street, an estimated $15.5M added.
  • The largest ChemoCentryx, Inc. seller in Q2 2019 was Sio Capital Management, an estimated $6.14M sold.

Based on aggregated 13F filings for Q2 2019.